Another option if Vyera is private, has sales and marketing infrastructure in place, access to capital and a pipeline, is to have a reverse merger into Cytodyn to become a larger public company. Samsung then handles the manufacturing. This absolves the need for a future BP buyout and the messiness of splitting licenses for different indications and royalties.